Literature DB >> 16670296

Differential effects of IL-27 on human B cell subsets.

Frédérique Larousserie1, Pascaline Charlot, Emilie Bardel, Josy Froger, Robert A Kastelein, Odile Devergne.   

Abstract

IL-27 is a novel heterodimeric cytokine of the IL-12 family that plays an important role in the regulation of T cell responses. Its role on human B cells has not been previously studied. In this study, we show that both chains of the IL-27 receptor complex, IL-27R and gp130, are constitutively expressed at the surface of naive and memory human tonsillar B cells, and are induced on germinal center B cells following CD40 stimulation. In naive B cells, IL-27 induced strong STAT1 and STAT3 phosphorylation, whereas it induced moderate STAT1 and low STAT3 activation in memory B cells. IL-27 induced T-bet expression in naive and memory B cells stimulated by CD40 or surface Ig engagement, but induced significant IL-12Rbeta2 surface expression in anti-Ig-stimulated naive B cells only. In anti-Ig-stimulated naive or memory B cells, IL-27 also induced CD54, CD86, and CD95 surface expression. In addition, IL-27 increased proliferation of anti-Ig-activated naive B cells and of anti-CD40-activated naive and germinal center B cells, but not of CD40-activated memory B cells. These data indicate that the B cell response to IL-27 is modulated during B cell differentiation and varies depending on the mode of B cell activation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16670296     DOI: 10.4049/jimmunol.176.10.5890

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

1.  IL-27p28 inhibits central nervous system autoimmunity by concurrently antagonizing Th1 and Th17 responses.

Authors:  Reiko Horai; Mary J Mattapallil; Wai Po Chong; Phyllis B Silver; Jun Chen; Ru Zhou; Yuri Sergeev; Rafael Villasmil; Chi-Chao Chan; Rachel R Caspi
Journal:  J Autoimmun       Date:  2013-09-07       Impact factor: 7.094

2.  Defective Toll-like receptor 9-mediated cytokine production in B cells from Bruton's tyrosine kinase-deficient mice.

Authors:  Maroof Hasan; Gabriela Lopez-Herrera; K Emelie M Blomberg; Jessica M Lindvall; Anna Berglöf; C I Edvard Smith; Leonardo Vargas
Journal:  Immunology       Date:  2007-08-28       Impact factor: 7.397

3.  Hepatitis C viraemia reversibly maintains subset of antigen-specific T-bet+ tissue-like memory B cells.

Authors:  L-Y Chang; Y Li; D E Kaplan
Journal:  J Viral Hepat       Date:  2016-12-20       Impact factor: 3.728

4.  Interleukin-27 promotes CD8+ T cell reconstitution following antibody-mediated lymphoablation.

Authors:  Katayoun Ayasoufi; Daniel B Zwick; Ran Fan; Suheyla Hasgur; Michael Nicosia; Victoria Gorbacheva; Karen S Keslar; Booki Min; Robert L Fairchild; Anna Valujskikh
Journal:  JCI Insight       Date:  2019-04-04

5.  Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis.

Authors:  Jin-Qing Liu; Zhenzhen Liu; Xuejun Zhang; Yun Shi; Fatemeh Talebian; Joseph W Carl; Chuan Yu; Fu-Dong Shi; Caroline C Whitacre; Joanne Trgovcich; Xue-Feng Bai
Journal:  J Immunol       Date:  2012-03-02       Impact factor: 5.422

6.  The presence of interleukin-27 during monocyte-derived dendritic cell differentiation promotes improved antigen processing and stimulation of T cells.

Authors:  Joo-Yong Jung; Lawton L Roberts; Cory M Robinson
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

7.  Signaling events involved in interleukin 27 (IL-27)-induced proliferation of human naive CD4+ T cells and B cells.

Authors:  Pascaline Charlot-Rabiega; Emilie Bardel; Céline Dietrich; Robert Kastelein; Odile Devergne
Journal:  J Biol Chem       Date:  2011-06-13       Impact factor: 5.157

Review 8.  Interleukin-27: balancing protective and pathological immunity.

Authors:  Christopher A Hunter; Rob Kastelein
Journal:  Immunity       Date:  2012-12-14       Impact factor: 31.745

9.  IL27: its roles in the induction and inhibition of inflammation.

Authors:  Joseph W Carl; Xue-Feng Bai
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

10.  Differential effect of IL-27 on developing versus committed Th17 cells.

Authors:  Mohamed El-behi; Bogoljub Ciric; Shuo Yu; Guang-Xian Zhang; Denise C Fitzgerald; Abdolmohamad Rostami
Journal:  J Immunol       Date:  2009-09-28       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.